Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 1 invite waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6621 Fannin St
Wb1100
Houston, TX 77030Phone+1 832-824-6422Fax+1 832-825-0164- Is this information wrong?
Summary
- Dr. Hao Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Connecticut, and New York.
Education & Training
Children's HospitalFellowship, Pediatric Pathology, 2013 - 2014
Boston University Medical CenterFellowship, Cytopathology, 2012 - 2013
Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 2008 - 2009
Xian Medicine UniversityClass of 2008
Certifications & Licensure
CT State Medical License 2021 - 2025
NY State Medical License 2019 - 2023
TX State Medical License 2014 - 2019
MA State Medical License 2012 - 2017- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Pathology - Pediatric
Publications & Presentations
PubMed
- 4 citationsGranulomatous Appendicitis in the Pediatric PopulationHao Wu, Maren Y. Fuller, Jennifer Pogoriler> ;Pediatric and Developmental Pathology. 2020 May 1
- 6 citationsPredisposing Conditions to Pediatric Hepatocellular Carcinoma and Association with Outcomes: Single-Center ExperienceElizabeth Cowell, Kalyani R. Patel, Andras Heczey, Milton J. Finegold, Rajkumar Venkatramani, Hao Wu, Dolores Lopez-Terrada, Tamir Miloh> ;Journal of Pediatric Gastroenterology and Nutrition. 2019 May 1
- 6 citationsExtrahepatic Nonreticuloendothelial Siderosis Is Not Specific to Gestational Alloimmune Liver Disease.Hao Wu, William S. Ferguson, Eumenia Costa da Cunha Castro, Debra L. Kearney, Milton J. Finegold, Kalyani R. Patel> ;Pediatric and Developmental Pathology. 2019 Feb 5
- Join now to see all
Press Mentions
- The Prevalence of Cryptococcal Antigen (CrAg) and Benefits of Pre-Emptive Antifungal Treatment Among HIV-Infected Persons with CD4+ T-cell Counts < 200 Cells/μL: Evidence Based on a Meta-AnalysisJune 12th, 2020
